About
- Senior Management
- Board of Directors
Science
Pipeline
Therapeutic Focus
Medical Affairs
Patients
- Patient Resources
Investors
Careers
Contact

Month: May 2021

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer

View Publication

by Craig Terrones

Recent Posts

No presentations available at this time
No presentations available at this time
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective in co-culture of human iPSC-derived motor neurons and muscle
Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease; Efficacy and Safety from the LIFT-AD Trial
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients with ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study

Recent Comments

Archives

January 2026
November 2025
April 2025
November 2024
March 2024
December 2023
December 2021
May 2021
July 2020
February 2010

Categories

Presentation
Publication
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

LeonaBio, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

info@leonabio.com

© 2026 LeonaBio. All rights reserved